DNA Demethylase Tet2 Suppresses Cisplatin-Induced Acute Kidney Injury.

Yinwu Bao,Mengqiu Bai,Huanhuan Zhu,Yuan,Ying Wang,Yunjing Zhang,Junni Wang,Xishao Xie,Xi Yao,Jianhua Mao,Xianghui Fu,Jianghua Chen,Yi Yang,Weiqiang Lin

DOI: https://doi.org/10.1038/s41420-021-00528-7

2021-01-01

Cell Death Discovery

Abstract:Demethylase Tet2 plays a vital role in the immune response. Acute kidney injury (AKI) initiation and maintenance phases are marked by inflammatory responses and leukocyte recruitment in endothelial and tubular cell injury processes. However, the role of Tet2 in AKI is poorly defined. Our study determined the degree of renal tissue damage associated with Tet2 gene expression levels in a cisplatin-induced AKI mice model. Tet2-knockout (KO) mice with cisplatin treatment experienced severe tubular necrosis and dilatation, inflammation, and AKI markers' expression levels than the wild-type mice. In addition, the administration of Tet2 plasmid protected Tet2-KO mice from cisplatin-induced nephrotoxicity, but not Tet2-catalytic-dead mutant. Tet2 KO was associated with a change in metabolic pathways like retinol, arachidonic acid, linolenic acid metabolism, and PPAR signaling pathway in the cisplatin-induced mice model. Tet2 expression is also downregulated in other AKI mice models and clinical samples. Thus, our results indicate that Tet2 has a renal protective effect during AKI by regulating metabolic and inflammatory responses through the PPAR signaling pathway.